CAR-T Cell Therapy

Revolutionary Cancer Immunotherapy

Chimeric Antigen Receptor (CAR) T-cell therapy is a major breakthrough in cancer treatment. China currently hosts the largest number of CAR-T clinical trials globally, offering hope even when conventional chemotherapy fails.

The Advantage of China

The cost of CAR-T therapy in the United States can exceed $400,000. In China, patients can access the same high-tech cell reprogramming technology for a fraction of that cost, typically between $45,000 and $65,000, including hospital stay.

How it Works

• Step 1: Collection of T-cells from the patient’s blood.
• Step 2: Genetic engineering of cells in a specialized laboratory to target specific cancer antigens.
• Step 3: Multiplication of the new “hunter” cells.
• Step 4: Re-infusion into the patient after mild lymphodepleting chemotherapy.

Our oncology centers provide 24/7 monitoring during the critical infusion phase to manage any potential side effects like cytokine release syndrome (CRS).